Most Complete Response Letters aren't about bad science. They're about bad records.

This white paper draws on analysis of 202 FDA Complete Response Letters to show why roughly 74% of CRL citations trace back to documentation, traceability, and manufacturing controls, not clinical or scientific failure.

It makes the case for a different operating model: one where the compliance record is the automatic result of doing the work itself, so life science organizations are perpetually inspection-ready without a separate compliance effort.

This white paper draws on analysis of 202 FDA Complete Response Letters to show why roughly 74% of CRL citations trace back to documentation, traceability, and manufacturing controls, not clinical or scientific failure.

It makes the case for a different operating model: one where the compliance record is the automatic result of doing the work itself, so life science organizations are perpetually inspection-ready without a separate compliance effort.